| Hemmie Schechter, RPH | |
|
855 El Camino Real, Palo Alto, CA 94301-2305 | |
| (650) 322-2150 | |
| Not Available |
| Full Name | Hemmie Schechter |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 855 El Camino Real, Palo Alto, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801246046 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 37681 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Hemmie Schechter, RPH 555 Bryant St # 926, Palo Alto, CA 94301-1704 Ph: (408) 219-2002 | Hemmie Schechter, RPH 855 El Camino Real, Palo Alto, CA 94301-2305 Ph: (650) 322-2150 |
News Archive
Depomed, Inc. today announced that its licensee has submitted a New Drug Application (NDA) for DM-1796 to the U.S. Food and Drug Administration (FDA) for the management of postherpetic neuralgia (PHN), or pain after shingles. DM-1796 is an investigational, extended release, once-daily tablet formulation of gabapentin designed to reduce dosing frequency and have a low incidence of side effects.
A study published today in The Journal of Pediatrics suggests that early-onset pancreatitis in children is strongly associated with certain genetic mutations and family history of pancreatitis.
In North America, for example, there are an estimated 233,000 new cases every year and 45,000 deaths. Despite the well-characterized role of genetics and reproductive risk factors, as well as the suggested roles of physical activity and alcohol, more than half of breast cancer risk remains unexplained.
Zynx Health CEO and President Scott Weingarten, MD, MPH will be speaking at IHI on clinical decision support, specifically focusing on the implications of clinical decision support for meaningful use of EHRs and American Recovery Reinvestment Act (ARRA) funding. Zynx is the leader in evidence-based and experience-based clinical decision support.
A new molecular imaging method can monitor the success of gene therapy in all areas of the brain, potentially allowing physicians to more effectively tackle brain conditions such as Parkinson's disease, Alzheimer's disease and multiple sclerosis.
› Verified 9 days ago
Dr. Laura Elizabeth Stoddard, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3801 Miranda Ave, Palo Alto, CA 94304 Phone: 650-493-5000 | |
See Lor, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 211 Quarry Rd, Palo Alto, CA 94304 Phone: 650-326-2300 | |
Jaimini Shah, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3801 Miranda Avenue, Palo Alto, CA 94304 Phone: 650-493-5000 | |
Tam Bang Nguyen, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4170 El Camino Real, Palo Alto, CA 94306 Phone: 650-858-2007 | |
Nidhu Baby Abraham, PHARM.D., BCPS Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3801 Miranda Ave, Palo Alto, CA 94304 Phone: 650-493-5000 | |
Eric Fujii, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 211 Quarry Rd Ste 108, Palo Alto, CA 94304 Phone: 650-326-2300 | |
Thuy Diem Huynh, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3801 Miranda, Palo Alto, CA 94034 Phone: 650-493-5000 |